How much does a box of dasatinib (Startax) cost in 2024?
Dasatinib (Dasatinib) is an oral anti-leukemia drug. As a tyrosine kinase inhibitor, it has been proven to have significant efficacy in the treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). In 2024, dasatinib (Startax) has been launched in China and has been included in the medical insurance directory, which provides leukemia patients with a more convenient and economical way to obtain it. It is understood that its price is about four to five thousand yuan. More accurate information about the specific price and medical insurance reimbursement can be obtained by consulting the local hospital pharmacy.

For patients with leukemia, drug treatment is key to their survival and quality of life. As an effective therapeutic drug, dasatinib (Dasatinib) can not only effectively inhibit the proliferation of leukemia cells, but also prolong the survival period and improve the quality of life of patients. Therefore, although the price is higher, the therapeutic effects it brings are immeasurable.
On the other hand, the price of foreign generic drugs of dasatinib (Startax) is relatively low, about a few hundred yuan. The ingredients of these generic drugs are basically the same as those of domestic original drugs, but their prices are cheaper. For some patients who are not financially well-off, these generic drugs may be a more affordable option. However, purchasing foreign generic drugs may also face some risks, such as uncertain product quality, unreliable purchasing channels, etc. Therefore, you need to consider carefully when choosing, and it is best to purchase under the guidance of a doctor.
In short, whether it is a domestic original drug or a foreign generic drug, patients should weigh and make a choice based on their own economic situation, medical insurance policy, and doctor's advice when choosing dasatinib. It is important to ensure continued access to effective treatment to improve quality of life and return to health as early as possible.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)